Emergent BioSolutions Inc. today announced that it has been awarded approximately $23 million to develop a novel multi-drug auto-injector for nerve agent antidote delivery. Emergent’s device is being designed for intramuscular self- [Read more]
The United States Agency for International Development (USAID) is inviting proposals under a Broad Agency Announcement (BAA) to generate novel tools and approaches that accelerate and sustain improved health outcomes in developing [Read more]
The US Army Engineer Research and Development Center (ERDC) has awarded a contract to Science Policy Consulting, LLC to identify knowledge and data gaps related to understanding the possible environmental impacts of [Read more]
The U.S. Department of Defense Tick-Borne Disease Research Program (TBDRP) aims to prevent tick-borne diseases and better diagnose and resolve associated illnesses. TBDRP was established in FY 2016 to support innovative and impactful research that addresses [Read more]
The Defense Advanced Research Projects Agency (DARPA) has awarded a cooperative agreement to Massachusetts General Hospital for research and development supporting the Safe Genes program. The Safe Genes program aims to deliver [Read more]
The Centers for Disease Control and Prevention has announced intentions to award a sole-source contract to the Johns Hopkins University Applied Physics Laboratory (JHU/APL) to provide enhancement and maintenance of the Electronic [Read more]
The Biomedical Advanced Research and Development Authority (BARDA) has announced intentions to award a research and development contract to Evolva in support of a “Novel Toxicant and Repellent for Arthropod-borne Virus Vectors (NTRAVV)”. [Read more]
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Virology Division, Pathogenesis and Immunology Branch has been tasked by the Defense Threat Reduction Agency to investigate a potential for enhanced efficacy [Read more]
The U.S. Army Medical Research and Materiel Command (USAMRMC) Special Immunizations Program (SIP) currently offers Investigational New Drug (IND) products to both military and civilian personnel at risk for pathogen and toxin exposure. [Read more]
The Department of Homeland Security (DHS) is seeking to develop methodologies to rapidly characterize the virulence of existing and emerging biothreats to inform risk assessments, disease preparedness and response activities. Traditional pathogen [Read more]
© 2017 Global Biodefense